Arjan A van de Loosdrecht

13PUBLICATIONS
49CO-AUTHORS
Stochastic analysis and modellingRegenerative medicine (incl. stem cells)Medical mycologyRespiratory diseasesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 14, 2026
Prognostic value of measuring LSC frequency in AML: a systematic review and meta-analysis.

|Sep 03, 2025
Computational measurable residual disease assessment in acute myeloid leukemia: a retrospective validation in the HOVON-SAKK-132 trial.

Tim R Mocking, Lukas H Haaksma, Tom Reuvekamp

|May 22, 2025
Applications of machine learning for immunophenotypic measurable residual disease assessment in acute myeloid leukemia.

Tim R Mocking, Arjan A van de Loosdrecht, Jacqueline Cloos

|Feb 27, 2025
CD34+CD38- leukemia stem cells predict clinical outcomes in acute myeloid leukemia patients treated non-intensively with hypomethylating agents.

Tom Reuvekamp, Lok Lam Ngai, Daphne den Hartog

|Apr 29, 2024
Benefits and risks of clofarabine in adult acute lymphoblastic leukemia investigated in depth by multi-state modeling.

Sjoerd J F Hermans, Yvette van Norden, Jurjen Versluis

|Mar 08, 2024
Myelodysplastic neoplasms dissected into indolent, leukaemic and unfavourable subtypes by computational clustering of haematopoietic stem and progenitor cells.

Margot F van Spronsen, Sofie Van Gassen, Carolien Duetz

Pageof 3

Frequent Collaborators

6 joint publications

Costa Bachas

5 joint publications

Jacqueline Cloos

5 joint publications

Lok Lam Ngai

4 joint publications

Tim R Mocking